Literature DB >> 1510793

Synthesis and evaluation of antimicrobial activity of new 4-nitroso and 4-diazopyrazole derivatives.

G Daidone1, S Plescia, D Raffa, B Maggio, D Schillaci.   

Abstract

Some N-(pyrazol-5-yl)-2-nitrobenzamides, variably substituted in the pyrazole nucleus as well as in the amidic group, were reacted in acetic acid media with potassium nitrite and hydrochloric acid. The different chemical behaviour of the reacted pyrazole derivatives in relation to the substitution pattern in both the pyrazole nucleus and the amidic group, was observed. All compounds isolated from the reaction mixtures (4-nitroso, 4-nitro, 4-diazo and 4-chloro derivatives) were evaluated by the agar diffusion method for their "in vitro" growth inhibitory activity against Candida albicans (our collection), Candida tropicalis ATCC 13803, Saccharomyces cerevisiae ATCC 36375, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853. The 1-methylpyrazole derivatives showed larger inhibition zones than the 1-phenyl ones in the antimicrobial tests.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510793

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  2 in total

1.  Discovery of a New Class of Sortase A Transpeptidase Inhibitors to Tackle Gram-Positive Pathogens: 2-(2-Phenylhydrazinylidene)alkanoic Acids and Related Derivatives.

Authors:  Benedetta Maggio; Demetrio Raffa; Maria Valeria Raimondi; Stella Cascioferro; Fabiana Plescia; Domenico Schillaci; Maria Grazia Cusimano; Ainars Leonchiks; Dmitrijs Zhulenkovs; Livia Basile; Giuseppe Daidone
Journal:  Molecules       Date:  2016-02-19       Impact factor: 4.411

2.  NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy.

Authors:  Garima Arora; Assirbad Behura; Tannu Priya Gosain; Ravi P Shaliwal; Saqib Kidwai; Padam Singh; Shamseer Kulangara Kandi; Rohan Dhiman; Diwan S Rawat; Ramandeep Singh
Journal:  Front Microbiol       Date:  2020-01-28       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.